Global Cardiovascular Surgical Devices and Technologies Market Size By Type (Beating Heart Surgery Systems, Perfusion Disposables), By Application (Medical Device Manufacturing Companies, Research Ins...

The Global Cardiovascular Surgical Devices and Technologies Market was valued at USD 12.8 billion in 2023 and is projected to reach USD 20.5 billion by 2031, growing at a CAGR of 6.2% during the forecast period of 2023-2031. The increasing prevalence of cardiovascular diseases (CVDs), technological advancements in surgical devices, and the rising adoption of minimally invasive procedures are major factors driving the market. Additionally, growing healthcare infrastructure in developing regions and increasing healthcare expenditure are fueling market growth.

Drivers

Increasing Prevalence of Cardiovascular Diseases

Cardiovascular diseases remain a leading cause of mortality worldwide. The growing aging population, unhealthy lifestyles, and increasing prevalence of conditions like hypertension and diabetes contribute to the rising incidence of heart diseases, thus driving demand for cardiovascular surgical devices.

Advancements in Surgical Technologies

The introduction of robot-assisted surgery, 3D imaging, biodegradable stents, and minimally invasive surgical techniques is revolutionizing cardiovascular procedures. These innovations enhance patient outcomes by reducing recovery time and surgical risks.

Growing Demand for Minimally Invasive Procedures

Minimally invasive cardiovascular surgeries, such as robotic-assisted heart surgeries and transcatheter procedures, are gaining traction due to their lower risks, shorter hospital stays, and improved patient recovery, thereby driving market growth.

Restraints

High Cost of Cardiovascular Surgical Devices

Advanced surgical equipment, such as robotic-assisted surgery systems and artificial heart valves, involve high costs, limiting their accessibility, especially in low-income countries. The significant investment required for technology adoption can hinder market expansion.

Stringent Regulatory Approvals

The cardiovascular surgical device industry is subject to strict regulatory requirements from organizations like the U.S. FDA, European Medicines Agency (EMA), and other national health bodies. Delays in approval processes can impact market growth.

Opportunity

Expansion in Emerging Markets

Developing regions, particularly Asia-Pacific and Latin America, are witnessing increased investments in healthcare infrastructure. Rising awareness of cardiovascular health, coupled with government initiatives, is expected to provide growth opportunities for market players.

Integration of Artificial Intelligence (AI) and Big Data in Surgery

AI-assisted cardiovascular surgery solutions are emerging as a game-changer by improving surgical precision, predicting patient risks, and enabling real-time monitoring. This trend is expected to create new market opportunities.

Market by System Type Insights

Cardiopulmonary Bypass Equipment dominated the market in 2023, accounting for the largest revenue share. These devices are essential in open-heart surgeries and are widely used across healthcare facilities.

Minimally Invasive Surgical Devices are expected to witness the highest growth rate due to their increasing adoption in less invasive heart procedures.

Market by End-Use Insights

Hospitals & Cardiac Centers held the largest share in 2023, driven by a growing number of cardiovascular procedures performed in specialized medical centers.

Ambulatory Surgical Centers (ASCs) are expected to grow rapidly due to the increasing preference for outpatient procedures that reduce hospital stays and healthcare costs.

Market by Regional Insights

North America dominated the cardiovascular surgical devices market in 2023, supported by an advanced healthcare infrastructure, high adoption rates of new surgical technologies, and the presence of key market players.

Asia-Pacific is projected to witness the highest growth rate due to increasing healthcare spending, rising cardiovascular disease prevalence, and improvements in medical infrastructure in countries like China, India, and Japan.

Europe holds a significant market share, with strong demand for innovative cardiovascular devices and government support for medical research and healthcare advancements.

Competitive Scenario

Key Players operating in the Global Cardiovascular Surgical Devices and Technologies Market include:

Medtronic plc

Abbott Laboratories

Boston Scientific Corporation

Edwards Lifesciences Corporation

Terumo Corporation

Johnson & Johnson

B. Braun Melsungen AG

Getinge Group

Siemens Healthineers

Lepu Medical Technology

These companies focus on product innovation, acquisitions, and strategic partnerships to enhance their market presence. For example:

In 2023, Medtronic introduced an AI-powered surgical assistance system for cardiovascular procedures.

In 2022, Abbott launched a next-generation transcatheter mitral valve replacement (TMVR) system, expanding its product portfolio.

In 2021, Boston Scientific acquired a cardiovascular device startup to strengthen its minimally invasive surgery division.

Scope of Work – Global Cardiovascular Surgical Devices and Technologies Market

Report Metric Details

Market Size (2023) USD 12.8 billion

Projected Market Size (2031) USD 20.5 billion

CAGR (2023-2031) 6.2%

Market Segments Cardiopulmonary Bypass Equipment, Minimally Invasive Surgical Devices, Others

Leading End-Use Segment Hospitals & Cardiac Centers

Leading Regional Market North America

Key Players Medtronic, Abbott, Boston Scientific, Edwards Lifesciences, Terumo Corporation, Siemens Healthineers, etc.

Growth Drivers Increasing Cardiovascular Disease Prevalence, Technological Advancements, Rising Demand for Minimally Invasive Surgeries

Opportunities AI Integration in Surgery, Expansion in Emerging Markets

Key Market Developments

March 2023 – Medtronic launched an AI-based robotic-assisted cardiac surgery system, improving precision and surgical outcomes.

September 2022 – Abbott introduced a transcatheter valve replacement system with enhanced durability and patient compatibility.

December 2021 – Edwards Lifesciences announced the acquisition of a start-up specializing in next-generation heart valves.

FAQs

1. What is the current market size of the Global Cardiovascular Surgical Devices and Technologies Market?

The market was valued at USD 12.8 billion in 2023 and is projected to grow steadily through 2031.

2. What is the major growth driver of the Global Cardiovascular Surgical Devices and Technologies Market?

The market is primarily driven by the increasing prevalence of cardiovascular diseases (CVDs), advancements in surgical technologies, and the growing adoption of minimally invasive procedures.

3. Which region is expected to dominate the market during the forecast period?

North America is expected to maintain its dominance due to its well-established healthcare infrastructure and high adoption of advanced cardiovascular surgical devices.

4. Which segment accounted for the largest market share in the Global Cardiovascular Surgical Devices and Technologies Market?

The Cardiopulmonary Bypass Equipment segment held the largest share in 2023, driven by the increasing number of heart surgeries.

5. Who are the key market players in the Global Cardiovascular Surgical Devices and Technologies Market?

Key players include Medtronic, Abbott, Boston Scientific, Edwards Lifesciences, Terumo Corporation, Siemens Healthineers, and others.

This comprehensive market report description provides an in-depth analysis of the Global Cardiovascular Surgical Devices and Technologies Market, offering valuable insights into market trends, growth drivers, opportunities, and competitive dynamics.